Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
Patricia A. Pellikka(Mayo Clinic), Larry K. Kvols(Moffitt Cancer Center), A. Jamil Tajik(Atrium Health Wake Forest Baptist), Henry C. Pitot(Mayo Clinic), J B Seward(Friedrich-Alexander-Universität Erlangen-Nürnberg), John A. Callahan(NOAA National Ocean Service), Bijoy K. Khandheria(Aurora St. Luke's Medical Center)
Cited by 608
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
|Journal of the American Society of Echocardiography|2009|4.4k
Recommendations for chamber quantification☆
|European Journal of Echocardiography|2006|3.6k
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
|European Journal of Echocardiography|2008|3.4k